Globus Medical (GMED) Tops Q4 EPS by 2c; offers guidance

Globus Medical (NYSE: GMED) reported Q4 EPS of $0.60, $0.02 better than the analyst estimate of $0.58. Revenue for the quarter came in at $616.53 million versus the consensus estimate of $608.17 million.

GUIDANCE:

Globus Medical sees FY2024 EPS of $2.68-$2.70, versus the consensus of $2.70. Globus Medical sees FY2024 revenue of $2.45-2.475 million, versus the consensus of $2.477 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• Micron Technology (MU) PT Raised to $1,550 at Needham
• AeroVironment restates quarterly financials, citing $89M goodwill error